Multidrug Rezistant Pulmonary Tuberculosis clinical trials

Explore recruiting multidrug rezistant pulmonary tuberculosis clinical trials.

Also recruiting in Europe

Multidrug Rezistant Pulmonary Tuberculosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis (DRTB-HDT).

Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Multidrug Rezistant Pulmonary Tuberculosis trials by city

Multidrug Rezistant Pulmonary Tuberculosis in Toronto Multidrug Rezistant Pulmonary Tuberculosis in Vancouver Multidrug Rezistant Pulmonary Tuberculosis in Montreal Multidrug Rezistant Pulmonary Tuberculosis in Calgary Multidrug Rezistant Pulmonary Tuberculosis in Edmonton Multidrug Rezistant Pulmonary Tuberculosis in Ottawa Multidrug Rezistant Pulmonary Tuberculosis in Winnipeg Multidrug Rezistant Pulmonary Tuberculosis in Quebec City Multidrug Rezistant Pulmonary Tuberculosis in Hamilton Multidrug Rezistant Pulmonary Tuberculosis in Kitchener Multidrug Rezistant Pulmonary Tuberculosis in London Multidrug Rezistant Pulmonary Tuberculosis in Halifax Multidrug Rezistant Pulmonary Tuberculosis in New York Multidrug Rezistant Pulmonary Tuberculosis in Los Angeles Multidrug Rezistant Pulmonary Tuberculosis in Chicago Multidrug Rezistant Pulmonary Tuberculosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease